Back to top
more

Cumberland Pharmaceuticals (CPIX)

(Delayed Data from NSDQ)

$1.76 USD

1.76
4,743

+0.06 (3.53%)

Updated Apr 26, 2024 03:28 PM ET

After-Market: $1.71 -0.05 (-2.84%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 36% (91 out of 252)

Industry: Medical - Drugs

Better trading starts here.

Zacks News

Cumberland Pharmaceuticals (CPIX) Reports Break-Even Earnings for Q2

Cumberland (CPIX) delivered earnings and revenue surprises of 100.00% and 5.66%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q2 Earnings Expected to Decline

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Industry Outlook Highlights: Xencor, Organogenesis Holdings, Cumberland Pharmaceuticals and Acer Therapeutics

Zacks Industry Outlook Highlights: Xencor, Organogenesis Holdings, Cumberland Pharmaceuticals and Acer Therapeutics

Kinjel Shah headshot

4 Small Drug Stocks Set to Escape the COVID-Led Industry Weakness

Some residual impact of the coronavirus pandemic is expected on the Medical-Drugs industry in the second quarter of 2021. However, with demand trends expected to improve, XNCR, ORGO, CPIX, and ACER may prove to be good additions to one's portfolio.

United Therapeutics (UTHR) Tyvaso DPI Gets FDA's Priority Tag

United Therapeutics' (UTHR) Tyvaso DPI is a drug device combination therapy, comprising the dry powder formulation of Tyvaso and a small, portable, dry powder inhaler.

Omeros (OMER) Announces Preliminary Data on MASP-3 Inhibitor

Omeros (OMER) announces initial results from a phase I study of OMS906.

Is Cumberland (CPIX) a Solid Growth Stock? 3 Reasons to Think " Yes "

Cumberland (CPIX) could produce exceptional returns because of its solid growth attributes.

Cumberland Pharmaceuticals (CPIX) Beats Q4 Earnings and Revenue Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 200.00% and 4.93%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Cumberland Pharmaceuticals (CPIX) Q3 Earnings and Revenues Surpass Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 128.57% and 7.45%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q3 Earnings Expected to Decline

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Cumberland Pharmaceuticals (CPIX) Q2 Earnings and Revenues Beat Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 166.67% and 3.54%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

All You Need to Know About Cumberland (CPIX) Rating Upgrade to Buy

Cumberland (CPIX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Cumberland Pharmaceuticals (CPIX) Q1 Earnings and Revenues Miss Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of -50.00% and -11.93%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast

Zacks.com featured highlights include: NeoPhotonics, eXp World, Cumberland and Medifast

4 Top-Ranked Liquid Stocks to Bet on for Alluring Returns

Here are four top-ranked liquid gems that investors can add to portfolio for remarkable returns.

Analysts Estimate Cumberland Pharmaceuticals (CPIX) to Report a Decline in Earnings: What to Look Out for

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks.com featured highlights include: MagnaChip Semiconductor, PJT Partners, eXp World and Cumberland Pharmaceuticals

Zacks.com featured highlights include: MagnaChip Semiconductor, PJT Partners, eXp World and Cumberland Pharmaceuticals

4 Top-Ranked Liquid Bets to Build a Successful Portfolio

Here are four excellent liquid stocks that can contribute to making an outstanding portfolio for yield-seeking investors.

Summit Therapeutics (SMMT) Catches Eye: Stock Jumps 8.9%

Summit Therapeutics (SMMT) saw a big move last session, as its shares jumped nearly 9% on the day, amid huge volumes.

Ampio (AMPE) Looks Good: Stock Adds 5.2% in Session

Ampio (AMPE) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day

LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day

Indrajit Bandyopadhyay headshot

3 Drugmakers Still Worth Betting on Amid Coronavirus Woes

Here we provide three stocks from the drug and biotech sector which can offer protection to an investor's portfolio amid stock market turmoil due to coronavirus crisis.

Translate Bio (TBIO) Surges: Stock Moves 5.5% Higher

Translate Bio (TBIO) saw a big move last session, as its shares jumped nearly 6% on the day, amid huge volumes.

Cumberland Pharmaceuticals (CPIX) Q4 Earnings and Revenues Beat Estimates

Cumberland (CPIX) delivered earnings and revenue surprises of 800.00% and 20.62%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: Cumberland Pharmaceuticals (CPIX) Q4 Earnings Expected to Decline

Cumberland (CPIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.